$83.07 Million in Sales Expected for Imperva Inc (IMPV) This Quarter
Equities analysts forecast that Imperva Inc (NYSE:IMPV) will report sales of $83.07 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Imperva’s earnings. The lowest sales estimate is $82.01 million and the highest is $83.80 million. Imperva reported sales of $68.41 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 21.4%. The firm is expected to report its next quarterly earnings results after the market closes on Wednesday, November 8th.
On average, analysts expect that Imperva will report full-year sales of $83.07 million for the current fiscal year, with estimates ranging from $320.90 million to $324.02 million. For the next financial year, analysts anticipate that the company will post sales of $379.96 million per share, with estimates ranging from $369.00 million to $386.30 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that that provide coverage for Imperva.
Imperva (NYSE:IMPV) last posted its quarterly earnings data on Thursday, July 27th. The software maker reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.15). The company had revenue of $74.44 million during the quarter, compared to the consensus estimate of $74.30 million. Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The company’s revenue was up 28.6% on a year-over-year basis. During the same quarter last year, the business earned ($0.23) earnings per share.
Several equities research analysts have recently commented on IMPV shares. Monness Crespi & Hardt lifted their price target on shares of Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a research report on Friday, July 28th. Evercore ISI set a $56.00 price target on shares of Imperva and gave the stock a “buy” rating in a research report on Friday, July 28th. Piper Jaffray Companies set a $58.00 price target on shares of Imperva and gave the stock a “buy” rating in a research report on Monday, August 28th. BidaskClub cut shares of Imperva from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 5th. Finally, Royal Bank Of Canada reiterated a “buy” rating and set a $49.00 price target on shares of Imperva in a research report on Wednesday, October 18th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and eleven have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $51.37.
In other news, Director Anthony J. Bettencourt sold 99,598 shares of the business’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the sale, the director now owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 2.20% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its position in Imperva by 4.3% during the second quarter. Vanguard Group Inc. now owns 2,439,240 shares of the software maker’s stock worth $116,718,000 after acquiring an additional 99,799 shares in the last quarter. BlackRock Inc. raised its position in Imperva by 11.3% during the second quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock worth $101,635,000 after acquiring an additional 215,170 shares in the last quarter. Eagle Asset Management Inc. raised its position in Imperva by 17.7% during the second quarter. Eagle Asset Management Inc. now owns 1,279,848 shares of the software maker’s stock worth $61,240,000 after acquiring an additional 192,625 shares in the last quarter. Clearbridge Investments LLC raised its position in Imperva by 47.0% during the first quarter. Clearbridge Investments LLC now owns 1,262,507 shares of the software maker’s stock worth $51,826,000 after acquiring an additional 403,809 shares in the last quarter. Finally, ETF Managers Group LLC bought a new stake in Imperva during the second quarter worth $41,888,000. 92.72% of the stock is currently owned by hedge funds and other institutional investors.
Imperva (IMPV) traded down 0.34% on Tuesday, hitting $43.70. 85,143 shares of the stock traded hands. The stock’s market cap is $1.48 billion. Imperva has a 12-month low of $34.40 and a 12-month high of $52.40. The stock has a 50-day moving average price of $43.75 and a 200 day moving average price of $45.96.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.